AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

OPTISCAN IMAGING LIMITED

0.145

0.000

Volume:40.34K

Turnover:6K

Market Cap:151.41M

PE:-20.71

High:0.155

Open:0.145

Low:0.140

Close:0.145

52wk High:0.200

52wk Low:0.080

Shares:1.04B

Float Shares:437.75M

Volume Ratio:0.29

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.007

EPS(LYR):-0.007

ROE:-52.41%

ROA:-28.53%

PB:7.99

PE(LYR):-20.71

Loading ...

Overview Company News Filings

Australia's Optiscan Rises After Imaging More than 80 Cases in ACL Study

Optiscan Imaging Says 84 Cases Imaged in Study Using Digital Pathology Imaging Device

MT Newswires Live

Optiscan Imaging Begins Head, Neck Cancer Imaging Study in US

MT Newswires Live

Optiscan Imaging - no Dividends Paid or Declared for FY26

THOMSON REUTERS

Optiscan Imaging - FY26 Loss for the Year Attributable to Owners A$7 Mln

THOMSON REUTERS

Optiscan Imaging - FY26 Revenue from Ordinary Activities Down 52.9% to A$448,769

THOMSON REUTERS

Optiscan Imaging Ltd-Preliminary Final Report

THOMSON REUTERS

Companies Like Optiscan Imaging (ASX:OIL) Are In A Position To Invest In Growth

Simply Wall St.

Australia's Optiscan Imaging Gains on Signing New Cross-border Research Deal

Optiscan Imaging to Commence US Clinical Study for InVue, InForm Devices in Breast Conserving Surgery, Shares Up 7%

MT Newswires Live

Optiscan Imaging Ltd-optiscan Signs New Research Agreement for Breast Study

THOMSON REUTERS

Optiscan Imaging Launches InSpecta Veterinary Imaging Device in US; Shares Hit 1.5-Year High

MT Newswires Live

Optiscan Imaging Says Half of Target Patients Imaged in Human Breast Cancer Imaging Study

MT Newswires Live

Optiscan Imaging Ltd-Second Anniversary of Optiscan and Mayo Clinic Agreement

THOMSON REUTERS

Non-Executive Director Ronnie Song Sold A Bunch Of Shares In Optiscan Imaging

Simply Wall St.

BRIEF-Optiscan Imaging Lodges US FDA Dossier For Inspecta For Veterinary Market

Optiscan Imaging Ltd - Lodges US FDA Dossier for Inspecta for Veterinary Market

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/OIL.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OIL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OIL.AU\",,,,,undefined,":{"symbol":"OIL.AU","market":"AU","secType":"STK","nameCN":"OPTISCAN IMAGING LIMITED","latestPrice":0.145,"timestamp":1789539120000,"preClose":0.145,"halted":0,"volume":40342,"delay":0,"changeRate":0,"nameEN":"OPTISCAN IMAGING LIMITED","floatShares":437752412,"shares":1044176632,"eps":-0.007,"marketStatus":"Not Yet Opened","change":0,"latestTime":"09-16 16:12:00 AEST","open":0.145,"high":0.155,"low":0.14,"amount":5914,"amplitude":0.103448,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.007,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.145,"openAndCloseTimeList":[[1789516800000,1789538400000]],"volumeRatio":0.29157860923282214,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"OIL.AU","preClose":0.16,"auctionPrice":0.145,"auctionVolume":95,"auction":3,"marketStatus":"盘后竞价","timestamp":1789452163456}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OIL.AU\",,,,,undefined,":{"symbol":"OIL.AU","floatShares":437752412,"roa":"-28.53%","roe":"-52.41%","lyrEps":-0.007,"volumeRatio":0.29157860923282214,"shares":1044176632,"dividePrice":0,"high":0.155,"amplitude":0.103448,"preClose":0.145,"low":0.14,"week52Low":0.08,"pbRate":"7.99","psRate":"41.90","week52High":0.2,"institutionHeld":0,"latestPrice":0.145,"eps":-0.007,"divideRate":0,"volume":40342,"delay":0,"ttmEps":-0.007,"open":0.145,"prevYearClose":0.1,"prevWeekClose":0.15,"prevMonthClose":0.155,"prevQuarterClose":0.12,"fiveDayClose":0.15,"twentyDayClose":0.16,"sixtyDayClose":0.12,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OIL.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-09-01","symbol":"OIL.AU","defaultRemindTime":1756684800000,"type":"split","dateTimestamp":1756648800000,"forFactor":993181,"toFactor":1000000,"ratio":0.993181},{"market":"AU","date":"2023-06-01","symbol":"OIL.AU","defaultRemindTime":1685577600000,"type":"split","dateTimestamp":1685541600000,"forFactor":979885,"toFactor":1000000,"ratio":0.979885}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OIL.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OIL.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666559449","title":"Australia's Optiscan Rises After Imaging More than 80 Cases in ACL Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2666559449","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666559449?lang=en_us&edition=fundamental","pubTime":"2026-09-10 09:40","pubTimestamp":1789004400,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Optiscan rises after imaging more than 80 cases in ACL study** Shares of Australia's Optiscan ImagingOIL.AXrise as much as 10% to A$0.165, their biggest intraday pct gain since August 19** Shares hit their highest levels since August 27** The medical technology firmsaysit has imaged more than 80 cases in a study with Australian Clinical Labs  using its InForm digital pathology imaging device** Company says study uses InForm device for real-time, slide-free cellular imaging at point of contact, in real-world pathology environment** Optiscan stock up 60%, YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nL4N452020:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","ACL.AU","OIL.AU","BK7084","BK7007","X2M.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666115556","title":"Optiscan Imaging Says 84 Cases Imaged in Study Using Digital Pathology Imaging Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2666115556","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666115556?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:56","pubTimestamp":1789001773,"startTime":"0","endTime":"0","summary":"Optiscan Imaging  said 84 cases were imaged in its digital pathology study with Australian Clinical Labs , using its InForm digital pathology imaging device, according to a Thursday Australian bourse filing.The device is providing real-time, slide-free cellular imaging at the point of contact. The cases imaged to date span a broad range of human tissue samples across multiple organs and systems as well as pathologies.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OIL.AU","BK7007","ACL.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664881394","title":"Optiscan Imaging Begins Head, Neck Cancer Imaging Study in US","url":"https://stock-news.laohu8.com/highlight/detail?id=2664881394","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664881394?lang=en_us&edition=fundamental","pubTime":"2026-09-01 08:38","pubTimestamp":1788223095,"startTime":"0","endTime":"0","summary":"Optiscan Imaging  began a new US-based head and neck cancer imaging study on 35-patients to assess the performance of Optiscan's InVue and InForm imaging platforms in head and neck tumor resections, according to a Tuesday Australian bourse filing.The InVue platform will be used during head and neck tumor resections to capture real-time, in vivo microscopic images within the surgical cavity following tumor removal. Following excision, tissue specimens will be analysed ex vivo using the InForm platform.Patient recruitment was initiated at Mayo Clinic in Rochester.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OIL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662268201","title":"Optiscan Imaging - no Dividends Paid or Declared for FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2662268201","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662268201?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:45","pubTimestamp":1787611548,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUEBM28YZ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","OIL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662252201","title":"Optiscan Imaging - FY26 Loss for the Year Attributable to Owners A$7 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662252201","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662252201?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:45","pubTimestamp":1787611548,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUEBM28YZ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OIL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662201232","title":"Optiscan Imaging - FY26 Revenue from Ordinary Activities Down 52.9% to A$448,769","url":"https://stock-news.laohu8.com/highlight/detail?id=2662201232","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662201232?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:45","pubTimestamp":1787611548,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUEBM28YZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","OIL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662012832","title":"Optiscan Imaging Ltd-Preliminary Final Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2662012832","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662012832?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:45","pubTimestamp":1787611548,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUEBM28YZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","OIL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657265236","title":"Companies Like Optiscan Imaging (ASX:OIL) Are In A Position To Invest In Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2657265236","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657265236?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:08","pubTimestamp":1786133305,"startTime":"0","endTime":"0","summary":"We can readily understand why investors are attracted to unprofitable companies. For example, although...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-oil/optiscan-imaging-shares/news/companies-like-optiscan-imaging-asxoil-are-in-a-position-to","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-oil/optiscan-imaging-shares/news/companies-like-optiscan-imaging-asxoil-are-in-a-position-to","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["OIL","BK7007","OIL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653173954","title":"Australia's Optiscan Imaging Gains on Signing New Cross-border Research Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2653173954","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653173954?lang=en_us&edition=fundamental","pubTime":"2026-07-22 13:30","pubTimestamp":1784698233,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Optiscan Imaging gains on signing new cross-border research deal** Shares of Australia's Optiscan ImagingOIL.AXrise as much as 8.9% to A$0.153** Stock erases most losses from Tuesday's session** Company signs a research agreement with US-based Mayo Clinic to test its breast cancer imaging platforms** Study is designed to potentially generate clinical evidence for planned FDA 510 submission, company says** Stock up 50% YTD, including current session's moves","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nL4N43O0BI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","OIL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653278752","title":"Optiscan Imaging to Commence US Clinical Study for InVue, InForm Devices in Breast Conserving Surgery, Shares Up 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653278752","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653278752?lang=en_us&edition=fundamental","pubTime":"2026-07-22 10:00","pubTimestamp":1784685621,"startTime":"0","endTime":"0","summary":"Optiscan Imaging  is set to start a US clinical study assessing the safety, performance and workflow utility of its InVue precision surgery imaging device and InForm digital pathology imaging device in patients undergoing breast-conserving surgery, according to a Wednesday Australian bourse filing.The company said the study will evaluate InVue for in vivo surgical imaging and InForm for ex vivo digital pathology imaging in 35 US patients, seeking to validate an integrated surgical-pathology workflow for US market entry and broader clinical expansion.The company's shares rose 7% in recent Wednesday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","OIL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653789872","title":"Optiscan Imaging Ltd-optiscan Signs New Research Agreement for Breast Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2653789872","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653789872?lang=en_us&edition=fundamental","pubTime":"2026-07-22 06:25","pubTimestamp":1784672749,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nTUEJVCRT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OIL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649605494","title":"Optiscan Imaging Launches InSpecta Veterinary Imaging Device in US; Shares Hit 1.5-Year High","url":"https://stock-news.laohu8.com/highlight/detail?id=2649605494","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649605494?lang=en_us&edition=fundamental","pubTime":"2026-07-07 11:37","pubTimestamp":1783395452,"startTime":"0","endTime":"0","summary":"Optiscan Imaging   said it has launched InSpecta, its veterinary-first microscopic imaging device, in the US after successfully submitting its regulatory documents to the US Food and Drug Administration  Center for Veterinary Medicine, according to a Tuesday Australian bourse filing.The company said InSpecta creates a new in-house imaging capability for veterinary practices, supporting faster clinical insight, workflow efficiency, and potential new revenue opportunities.The launch means Optiscan has brought its first clinical device to market, creating a regulatory pathway that should support future product submissions, it added.The company's shares rose 11% in recent Tuesday trade and earlier hit their highest price since February 2025.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","OIL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640138859","title":"Optiscan Imaging Says Half of Target Patients Imaged in Human Breast Cancer Imaging Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2640138859","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640138859?lang=en_us&edition=fundamental","pubTime":"2026-06-04 08:21","pubTimestamp":1780532515,"startTime":"0","endTime":"0","summary":"Optiscan Imaging  said 25 of the target 50 patients were imaged in its first in-human breast cancer imaging study at Royal Melbourne Hospital in Victoria, reaching a halfway mark milestone, according to a Thursday Australian bourse filing.The study is assessing surgical margins in breast cancer patients undergoing lumpectomy procedures using the InVue precision surgery imaging device for in vivo imaging and the InForm digital pathology imaging device for ex vivo imaging, per the filing.InVue is used intraoperatively in the resection cavity to generate live in vivo images immediately after tumor removal, while InForm is used to analyze the excised tissue.Clinical readouts of the analyzed cases to date show nine with clear margins, four with narrowly clear margins, and five with involved margins, the company said. There were no reported adverse events related to intravenous sodium fluorescein contrast agent injections.The study was expanded to a second clinical site to accelerate recruit","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","OIL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640698424","title":"Optiscan Imaging Ltd-Second Anniversary of Optiscan and Mayo Clinic Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2640698424","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640698424?lang=en_us&edition=fundamental","pubTime":"2026-06-01 09:32","pubTimestamp":1780277546,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nTUE23HVMP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","OIL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638254795","title":"Non-Executive Director Ronnie Song Sold A Bunch Of Shares In Optiscan Imaging","url":"https://stock-news.laohu8.com/highlight/detail?id=2638254795","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638254795?lang=en_us&edition=fundamental","pubTime":"2026-05-27 04:02","pubTimestamp":1779825730,"startTime":"0","endTime":"0","summary":"Anyone interested in Optiscan Imaging Limited ( ASX:OIL ) should probably be aware that the Non-Executive Director...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-oil/optiscan-imaging-shares/news/non-executive-director-ronnie-song-sold-a-bunch-of-shares-in","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-oil/optiscan-imaging-shares/news/non-executive-director-ronnie-song-sold-a-bunch-of-shares-in","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["OIL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631748965","title":"BRIEF-Optiscan Imaging Lodges US FDA Dossier For Inspecta For Veterinary Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2631748965","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631748965?lang=en_us&edition=fundamental","pubTime":"2026-04-30 09:36","pubTimestamp":1777513001,"startTime":"0","endTime":"0","summary":"BRIEF-Optiscan Imaging Lodges US FDA Dossier For Inspecta For Veterinary MarketApril 30 (Reuters) - Optiscan Imaging Ltd OIL.AX:LODGES US FDA DOSSIER FOR INSPECTA FOR VETERINARY MARKETFurther company coverage: OIL.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nFWN41C1WU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OIL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631783885","title":"Optiscan Imaging Ltd - Lodges US FDA Dossier for Inspecta for Veterinary Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2631783885","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631783885?lang=en_us&edition=fundamental","pubTime":"2026-04-30 06:48","pubTimestamp":1777502911,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nFWN41C1WU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","OIL.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":17,"code":"91000000","status":"200"}]}}